Skip to content

Study on Olfactory Dysfunction in Schizophrenia and Its Brain Mechanisms in Relation to Core Symptoms

Study on Olfactory Dysfunction in Schizophrenia and Its Brain Mechanisms in Relation to Core Symptoms

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125174
Enrollment
Unknown
Registered
2026-05-21
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

Exposure group(Suffering from schizophrenia):None
Non-exposure group(healthy person):None

Sponsors

Peking University Sixth Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Patient Group: (1)Meets the DSM-5 diagnostic criteria for schizophrenia; (2)Aged 18 to 45 years; Han ethnicity; right-handed; (3)Not currently taking any medication or currently taking second-generation antipsychotics other than clozapine; (4) Capable of cooperating with olfactory assessments, symptom evaluations, and imaging examinations. 2.Control Group: (1)Aged 18 to 45 years; Han ethnicity; right-handed; (2)No history of mental illness and no family history of mental illness within three generations on either side; (3) Normal cognitive function and capable of cooperating with olfactory assessments and imaging examinations.

Exclusion criteria

Exclusion criteria: 1. Patient Group (1)Comorbidity with other mental disorders; (2)Currently undergoing MECT treatment; (3)History of traumatic brain injury, neurological disorders, or severe physical illness; (4)Severe nasal septal deviation, nasal polyposis, or history of nasal surgery; (5)History of respiratory tract infections within the past two weeks; (6)Intellectual disability, dementia, or co-occurring substance dependence and substance abuse; (7)Pregnant or breastfeeding women; (8)Individuals with claustrophobia, metallic implants, or other conditions rendering them unable to tolerate MRI scanning. 2.Control Group (1)History of traumatic brain injury, neurological disorders, or severe physical illnesses; (2)Severe nasal septal deviation, nasal polyposis, or history of nasal surgery; (3)History of respiratory tract infections within the past two weeks; (4)Intellectual disability, dementia, or coexisting substance dependence and substance abuse; (5)Pregnant or breastfeeding women; (6)Individuals unable to tolerate MRI due to conditions such as claustrophobia or the presence of metallic implants.

Design outcomes

Primary

MeasureTime frame
Odor threshold;Odor recognition;Odor discrimination;

Countries

China

Contacts

Public ContactWentian Dong

Peking University Sixth Hospital

dongwentian@bjmu.edu.cn+86 130 0118 6672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026